| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/3/264:05 PM | -$1.70 | -$0.78 | +54.1% | -160% | $190.4M | $194.6M | +2.2% | +64% | |
| Q2 '26 | 8/6/267:30 AM | -$0.25 | -$0.43GAAP | -72.0% | +10% | $167.2M | $173.9M | +4.0% | +69% | |
| Q1 '26 | 5/6/264:05 PM | -$0.39 | -$0.16GAAP | +59.0% | +75% | $149.8M | $162.1M | +8.2% | +107% | |
| Q4 '25 | 2/23/264:05 PM | -$0.07 | -$0.20GAAP | -186% | +67% | $144.7M | $151.7M | +4.8% | +128% | |
| Q3 '25 | 11/4/254:05 PM | -$0.34 | -$0.30GAAP | +11.8% | +51% | $115.3M | $118.7M | +2.9% | +147% | |
| Q2 '25 | 8/6/254:05 PM | -$0.35 | -$0.48GAAP | -37.1% | +45% | $94.8M | $102.7M | +8.2% | +152% | |
| Q1 '25 | 5/1/254:05 PM | -$0.63 | -$0.64GAAP | -1.6% | +37% | $71.6M | $78.3M | +9.4% | +184% |
GAAP = diluted EPS as filed with the SEC. Other EPS figures are adjusted (non-GAAP), the basis analysts estimate.